Coya Therapeutics Inc [COYA] stock prices are up 5.28% to $6.38 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The COYA shares have gain 10.19% over the last week, with a monthly amount drifted -4.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Coya Therapeutics Inc [NASDAQ: COYA] stock has seen the most recent analyst activity on July 09, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $16. Previously, D. Boral Capital started tracking the stock with Buy rating on December 04, 2024, and set its price target to $15.
The stock price of Coya Therapeutics Inc [COYA] has been fluctuating between $4.65 and $8.29 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Coya Therapeutics Inc [NASDAQ: COYA] shares were valued at $6.38 at the most recent close of the market. An investor can expect a potential return of 166.46% based on the average COYA price forecast.
Analyzing the COYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.95% with Operating Profit Margin at -15186.43%, Pretax Profit Margin comes in at -14428.89%, and Net Profit Margin reading is -14427.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.86 and Total Capital is -0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.17 points at the first support level, and at 5.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.49, and for the 2nd resistance point, it is at 6.60.
Ratios To Look Out For
It’s worth pointing out that Coya Therapeutics Inc [NASDAQ:COYA]’s Current Ratio is 8.73. In addition, the Quick Ratio stands at 8.73 and the Cash Ratio stands at 6.61. Considering the valuation of this stock, the price to sales ratio is 33.46, the price to book ratio is 3.91.
